TELO
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ: TELO · HEALTHCARE · BIOTECHNOLOGY
$1.40
-3.45% today
Updated 2026-04-30
Market cap
$99.72M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Telomir Pharmaceuticals, Inc. Common Stock (TELO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-8.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+40.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+8.4%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.06 | — | $1.21 | $1.31 | +8.3% |
| 2025-11-10 | $-0.03 | +57.1% | $1.31 | $1.42 | +8.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-0.06 | — | — | — |
| 2025-09-30 | $-0.07 | $-0.03 | +57.1% | — | — |
| 2025-06-30 | $-0.08 | $-0.17 | -112.5% | — | — |
| 2025-03-31 | $-0.10 | $-0.07 | +30.0% | — | — |
| 2024-12-31 | $-0.05 | $-0.10 | -100.0% | $18.79M | — |
| 2024-09-30 | — | $-0.20 | — | — | — |
| 2024-06-30 | — | $-0.05 | — | — | — |
| 2024-03-31 | — | $-0.23 | — | — | — |
Frequently asked questions
Has Telomir Pharmaceuticals, Inc. Common Stock beaten earnings estimates?
Telomir Pharmaceuticals, Inc. Common Stock has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -8.5% over the last 3 quarters.
How does TELO stock react to earnings?
TELO stock has moved an average of +8.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.